Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Nangarhar, Afghanistan - Takeaways - MDSpire

Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Nangarhar, Afghanistan

  • By

  • Shah Agha Salehi

  • Sant Muangnoicharoen

  • Natthida Sriboonvorakul

  • Janjira Thaipadungpanit

  • Jittima Dhitavat

  • Udomsak Silachamroon

  • Wiwat Chancharoenthana

  • February 5, 2026

  • 0 min

Share

  • 1

    Rifampicin-resistant tuberculosis (RR-TB) poses significant challenges in Afghanistan, where TB remains a leading cause of infectious disease mortality.

  • 2

    The study in Nangarhar Province aimed to estimate the prevalence of RR-TB and identify associated risk factors using Xpert MTB/RIF data.

  • 3

    Key risk factors for MDR/RR-TB include previous TB treatment, prolonged exposure to infectious cases, and household crowding.

  • 4

    The observational study included a cross-sectional analysis and a case-control study conducted at major TB treatment centers in Jalalabad.

  • 5

    Findings from this study are intended to inform targeted interventions to improve TB care and reduce transmission in the region.

Original Source(s)

Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Nangarhar, Afghanistan

  • by Shah Agha Salehi, Sant Muangnoicharoen, Natthida Sriboonvorakul, Janjira Thaipadungpanit, Jittima Dhitavat, Udomsak Silachamroon, Wiwat Chancharoenthana

  • February 5, 2026

Related Content

Evaluation of antibiotic consumption and resistance patterns among neonates: a 10-year retrospective study

Respiratory chain gene mutations associated with global phylogenetic clustering of drug-resistant Mycobacterium tuberculosis revealed by whole-genome sequencing

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.